The NYT's 'Me Too' Reporter Ran Interference for Graham Platner This Week
'Christian! Love Means You Let Us Sin All We Want to, and Pay...
Election Security Is Nonnegotiable
The Chickens Have Come Home to Roost for Cleveland Clinic
The Beleaguered State of Maine
Worry About Climate Fearmongering – Not Climate Change
Treasury Is Right to Examine the National Security Risks of Foreign-Funded Lawsuits
The Algorithm Knows Where, Not Why
Timely Care Is Compassionate Care. Then Why Are Families Still Waiting?
What Is Good Economic Policy?
Waning Prominence of Pride Month Is Cause for Hope
Paid Experts and Junk Science Corrupt America’s Courts
Terror in the Twelfth
U.S. Wins Big in World Cup Opener
WATCH: Tren de Aragua Leader Killed in American Strike, Trump Announces
Tipsheet

Biden-Era Abortion Pill Mailing Rule Temporarily Suspended by Appeals Court

Biden-Era Abortion Pill Mailing Rule Temporarily Suspended by Appeals Court
AP Photo/Manuel Balce Ceneta

A federal appeals court in Louisiana has temporarily blocked a Biden-era federal rule that allowed an abortion drug called mifepristone to be sent via mail.

On May 1, the 5th Circuit Court of Appeals granted a stay that temporarily blocked the mailing of the abortion drug while litigation proceeds. 

Advertisement

The state of Louisiana had sued the Food and Drug Administration, U.S. Department of Health and Human Services, and DHS Secretary Robert F. Kennedy Jr. to stop the rule enacted during the Biden administration. 

The Biden FDA had allowed the abortion drug to be prescribed online and mailed without an in-person doctor visit. 

Louisiana sued over the rule under the Administrative Procedure Act. The state said that the FDA approved the mail-order drug based on flawed or missing data, which caused many illegal abortions in the state. 

Taxpayers picked up the tab to care for women who were harmed by mifepristone, court documents said. 

“By ending the in-person dispensing requirement, FDA opened the door for mifepristone to be remotely prescribed to Louisiana women,” the ruling says. “The record shows that the policy now facilitates nearly 1,000 illegal abortions in Louisiana per month.”

The appeals court said that the FDA’s 2023 law interferes with Louisiana law and gives it standing to challenge the law. 

The lawsuit says that Medicaid paid $92,000 from two women who needed emergency care in 2025 caused by complications from out-of-state mifepristone. 


 2026-05-01-  by  scott.mcclallen 



Advertisement

Editor’s Note: Do you enjoy Townhall’s conservative reporting that takes on the radical Left and woke media? Support our work so that we can continue to bring you the truth.

Join Townhall VIP and use promo code FIGHT to receive 60% off your membership.

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos

Advertisement
Advertisement
Advertisement